General Moly (GMO) Reports Q4 Loss of $0.02/Share
Tweet
Share
E-mailGet Alerts GMO Hot Sheet
Price: $0.11 --0%
Financial Fact:
CONSOLIDATED NET LOSS: -2.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
CONSOLIDATED NET LOSS: -2.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
General Moly (NYSE: GMO) reported Q4 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on General Moly (GMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Radnostix revenue falls 27% amid product recalls and FDA actions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
